Eosinophils in cancer immunity: context-dependent plasticity, biomarker potential, and therapeutic opportunities
It is argued that clinically useful eosinophil biomarkers will require integration of abundance with phenotype, spatial localization, tissue compartment, and treatment context, and that most reported associations remain prognostic rather than demonstrated predictors of treatment benefit.